SP

Smit Pathak

Project Manager at Evidera

Smit Pathak is an experienced professional in the pharmaceutical and healthcare sectors, currently serving as an Associate Project Manager at Evidera since August 2022. Previously, Smit held positions as a Research Assistant at Evidera and as an Associate Consultant (HEOR/RWS) at IQVIA from December 2020 to August 2022. Prior experience includes working as an Analyst at Excelra (August 2018 - December 2020) and as a Research Fellow at the National Institute of Pharmaceutical Education and Research (NIPER) in Mohali from June 2017 to June 2018, where a project focused on recombinant human acetylcholinesterase was undertaken. Smit began professional training at Rekvina Pharmaceuticals Pvt. Ltd. in June 2015. Smit holds a Master of Science in Biotechnology from NIPER (2016-2018) and a Bachelor of Pharmacy from The Maharaja Sayajirao University of Baroda (2012-2016).

Location

Bengaluru, India

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Evidera

1 followers

Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.